Dr. Gerds on the Treatment of Polycythemia Vera

By Aaron Gerds, MD, Raj Chakraborty, MD, Ashwin Kishtagari, MD - Last Updated: July 31, 2024

In this episode of the “Blood Cancer Talks” podcast, hosts Raj Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD, spoke with Aaron Gerds, MD, of the Cleveland Clinic Taussig Cancer Institute, to hear how he makes treatment choices in patients with polycythemia vera.

The episode references key papers from the REVEAL, MAJIC PV, Cyto-PV, PROUD-PV, CONTINUATION-PV, and RESPONSE trials.

Dr. Schmidt on Quadruplet Therapy for Newly Diagnosed, Transplant Ineligible MM

Discussing Lower-Risk MDS Treatment Options With Dr. Stahl

Dr. Iacoboni Highlights Key Lymphoma Abstracts Presented This Year

MRD Use in Multiple Myeloma: Clinical Practice, Clinical Trials, and Drug Approval

Dr. Tefferi on Recent Ruxolitinib Combination Trials for Myelofibrosis

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer

Dr. Gerds on the Treatment of Polycythemia Vera

Related